Accuray reports treatment milestone in Rotterdam

By staff writers

March 28, 2018 -- Radiation oncology firm Accuray said the Erasmus Medical Center in Rotterdam, the Netherlands, has completed the first patient treatment using an online-adaptive approach together with its CyberKnife system.

The patient was treated for oligometastases in the pelvic region. The procedure was performed as part of a new clinical trial at Erasmus Medical Center to evaluate stereotactic body radiation therapy provided by the CyberKnife platform for treating oligometastatic disease in the pelvic or para-aortic region, Accuray said.

Accuray and the institution are partnering to develop an integrated imaging technology tailored for use with CyberKnife in treating oligometastastic disease.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking